FibroGen Inc
(NAS:FGEN)
$
0.58
0.001 (0.17%)
Market Cap: 58.45 Mil
Enterprise Value: 48.65 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 49/100 FibroGen Inc at SVB Leerink Global Healthcare Conference (Virtual) Transcript
Feb 25, 2021 / 08:40PM GMT
Release Date Price:
$49.86
(-5.94%)
Geoffrey Craig Porges
SVB Leerink LLC, Research Division - Director of Therapeutics Research & Diversified Biopharma and Senior Research Analyst
Good afternoon, everybody, and welcome to our next company presentation here at the Global Healthcare Conference. I'm joined by Enrique Conterno, who's the Chief Executive Officer of FibroGen; and Mike Tung from the Investor Relations group of FibroGen. Enrique and Mike, thank you for joining us today.
Enrique A. Conterno
FibroGen, Inc. - CEO & Director
Now thank you very much for the invitation, Geoff. Pleasure to be here. Thanks, Geoff.
Geoffrey Craig Porges;Enrique A. Conterno<
SVB Leerink LLC, Research Division - Director of Therapeutics Research & Diversified Biopharma and Senior Research Analyst
I look forward to chatting as it's a very exciting time for FibroGen. Enrique, so maybe you could give us a sense of what you're all focused on, what the activities that are engaging your leadership team and the rest of the company right now.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot